November 07, 2018

United States of America, ex v. Amgen, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 03, 2020

    2nd Circ. Sends FCA Discount Case For 'Original Source' Look

    The Second Circuit on Wednesday revived a former Amgen Inc. sales representative's False Claims Act suit accusing numerous oncology practices of bilking Medicare, saying a lower court must examine whether the whistleblower is the original source of the allegations.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS